https://biotechmorning.com/news/china-supply-chain-regulations-biopharma-threat Biotech Morning en 2026-05-06T14:16:46.050Z China Just Made It Illegal to Leave Its Drug Supply Chain https://biotechmorning.com/news/bayer-perfuse-acquisition-ophthalmology-implant Biotech Morning en 2026-05-06T14:16:06.748Z Bayer Just Bet $2.45 Billion on an Eye Implant Most People Haven't Heard Of https://biotechmorning.com/news/cellcentric-220m-epigenetics-multiple-myeloma Biotech Morning en 2026-05-06T14:15:20.346Z The $220M Bet on an Epigenetic Light Switch for Blood Cancer https://biotechmorning.com/news/novo-nordisk-cagrisema-device-decision Biotech Morning en 2026-05-06T14:14:36.934Z Novo Nordisk Just Killed Part of Its Biggest Obesity Drug. Here's Why That's Good News. https://biotechmorning.com/news/biontech-restructuring-1860-jobs-oncology-pivot Biotech Morning en 2026-05-06T14:13:58.109Z BioNTech Built a Vaccine Empire. Now It's Tearing It Down. https://biotechmorning.com/news/gsk-siranbio-obesity-oligonucleotide-deal Biotech Morning en 2026-05-06T14:13:15.472Z GSK Just Paid $55M for a Drug That Melts Fat (Not Muscle) https://biotechmorning.com/news/madrigal-billion-dollar-bet-silencing-genes Biotech Morning en 2026-05-06T14:12:31.435Z Madrigal's Billion-Dollar Bet on Silencing Genes https://biotechmorning.com/news/fda-real-time-clinical-trial-data-sharing-pilot Biotech Morning en 2026-05-06T14:11:51.176Z The FDA Just Blew Up 60 Years of Clinical Trial Protocol https://biotechmorning.com/news/latus-bio-97m-low-dose-gene-therapy-huntingtons Biotech Morning en 2026-05-05T14:13:00.603Z The $97M Bet That Less Is More in Gene Therapy https://biotechmorning.com/news/cytokinetics-aficamten-data-challenges-camzyos Biotech Morning en 2026-05-05T14:12:18.628Z Cytokinetics Just Handed Bristol Myers Its Biggest Headache Yet https://biotechmorning.com/news/amgen-tepezza-monopoly-viridian-phase-3-win Biotech Morning en 2026-05-05T14:11:38.032Z Amgen's $2B Monopoly Just Got a Lot Less Comfortable https://biotechmorning.com/news/passage-bio-layoffs-fda-gene-therapy Biotech Morning en 2026-05-05T14:10:59.944Z Passage Bio Just Lost 75% of Its Team. The FDA Letter That Broke Them. https://biotechmorning.com/news/biotech-avengers-abia-trade-group-launch Biotech Morning en 2026-05-05T14:10:14.410Z Biotech's Avengers Just Assembled (But Can They Actually Fight?) https://biotechmorning.com/news/odyssey-therapeutics-ipo-filing-2026 Biotech Morning en 2026-05-05T14:09:33.575Z The $700M Startup That's Never Sold a Drug Just Filed to Go Public https://biotechmorning.com/news/celcuity-gedatolisib-breast-cancer-pik3ca-mutant-wild-type Biotech Morning en 2026-05-05T14:08:50.560Z The Breast Cancer Drug That Doesn't Care About Your Tumor's Genetics